Effects of HIV-1 Tat and Methamphetamine on Blood-Brain Barrier Integrity and Function In Vitro

被引:23
|
作者
Patel, Sulay [1 ]
Leibrand, Crystal R. [1 ]
Palasuberniam, Preetha [1 ]
Couraud, Pierre-Olivier [2 ]
Weksler, Babette [3 ]
Jahr, Fay M. [1 ]
McClay, Joseph L. [1 ]
Hauser, Kurt F. [4 ]
McRae, MaryPeace [1 ]
机构
[1] Virginia Commonwealth Univ, Sch Pharm, Dept Pharmacotherapy & Outcomes Sci, Richmond, VA 23284 USA
[2] Inst Cochin, Paris, France
[3] Weill Cornell Med Coll, New York, NY USA
[4] Virginia Commonwealth Univ, Dept Pharmacol & Toxicol, Sch Med, Richmond, VA USA
基金
美国国家卫生研究院;
关键词
blood-brain barrier; HIV-1; drug abuse; methamphetamine; P-glycoprotein; Tat; drug transport; human immunodeficiency virus; HUMAN-IMMUNODEFICIENCY-VIRUS; CENTRAL-NERVOUS-SYSTEM; ENDOTHELIAL-CELL-LINE; P-GLYCOPROTEIN SUBSTRATE; PROTEASE INHIBITORS; NEUROCOGNITIVE DISORDERS; ANTIRETROVIRAL THERAPY; CACO-2; CELLS; PERIVASCULAR MACROPHAGES; EPITHELIAL TRANSPORT;
D O I
10.1128/AAC.01307-17
中图分类号
Q93 [微生物学];
学科分类号
071005 ; 100705 ;
摘要
Human immunodeficiency (HIV) infection results in neurocognitive deficits in about one half of infected individuals. Despite systemic effectiveness, restricted antiretroviral penetration across the blood-brain barrier (BBB) is a major limitation in fighting central nervous system (CNS)-localized infection. Drug abuse exacerbates HIV-induced cognitive and pathological CNS changes. This study's purpose was to investigate the effects of the HIV-1 protein Tat and methamphetamine on factors affecting drug penetration across an in vitro BBB model. Factors affecting paracellular and transcellular flux in the presence of Tat and methamphetamine were examined. Transendothelial electrical resistance, ZO-1 expression, and lucifer yellow (a paracellular tracer) flux were aspects of paracellular processes that were examined. Additionally, effects on P-glycoprotein (P-gp) and multidrug resistance protein 1 (MRP-1) mRNA (via quantitative PCR [qPCR]) and protein (via immunoblotting) expression were measured; Pgp and MRP-1 are drug efflux proteins. Transporter function was examined after exposure of Tat with or without methamphetamine using the P-gp substrate rhodamine 123 and also using the dual P-gp/MRP-1 substrate and protease inhibitor atazanavir. Tat and methamphetamine elicit complex changes affecting transcellular and paracellular transport processes. Neither Tat nor methamphetamine significantly altered P-gp expression. However, Tat plus methamphetamine exposure significantly increased rhodamine 123 accumulation within brain endothelial cells, suggesting that treatment inhibited or impaired P-gp function. Intracellular accumulation of atazanavir was not significantly altered after Tat or methamphetamine exposure. Atazanavir accumulation was, however, significantly increased by simultaneous inhibition of P-gp and MRP. Collectively, our investigations indicate that Tat and methamphetamine alter aspects of BBB integrity without affecting net flux of paracellular compounds. Tat and methamphetamine may also affect several aspects of transcellular transport.
引用
收藏
页数:15
相关论文
共 50 条
  • [1] Permeability of the blood-brain barrier to HIV-1 Tat
    Banks, WA
    Robinson, SM
    Nath, A
    EXPERIMENTAL NEUROLOGY, 2005, 193 (01) : 218 - 227
  • [2] In vitro modeling of blood-brain barrier deregulation by HIV-1 Tat and opioids
    Maubert, Monique
    Kercher, Katherine
    Strazza, Marianne
    Pirrone, Vanessa
    Lin, Wei
    Feng, Rui
    Wigdahl, Brian
    Nonnemacher, Michael
    JOURNAL OF NEUROVIROLOGY, 2016, 22 : S50 - S50
  • [3] BLOOD-BRAIN BARRIER COMPROMISE BY HIV-1 TAT AND OPIOIDS IN AN IN VITRO MODEL.
    Maubert, M. E.
    Kercher, K. A.
    Strazza, M.
    Pirrone, V
    Lin, W.
    Feng, R.
    Wigdahl, B.
    Nonnemacher, M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2016, 11 : S30 - S30
  • [4] Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice
    Kara M. Rademeyer
    Sara R. Nass
    Austin M. Jones
    Michael Ohene-Nyako
    Kurt F. Hauser
    MaryPeace McRae
    Journal of NeuroVirology, 2024, 30 : 1 - 21
  • [5] Fentanyl dysregulates neuroinflammation and disrupts blood-brain barrier integrity in HIV-1 Tat transgenic mice
    Rademeyer, Kara M.
    R. Nass, Sara
    Jones, Austin M.
    Ohene-Nyako, Michael
    Hauser, Kurt F.
    McRae, MaryPeace
    JOURNAL OF NEUROVIROLOGY, 2024, 30 (01) : 1 - 21
  • [6] HIV-1 Tat and opioids act independently to limit antiretroviral brain concentrations and reduce blood-brain barrier integrity
    Leibrand, Crystal R.
    Paris, Jason J.
    Jones, Austin M.
    Masuda, Quamrun N.
    Halquist, Matthew S.
    Kim, Woong-Ki
    Knapp, Pamela E.
    Kashuba, Angela D. M.
    Hauser, Kurt F.
    McRae, MaryPeace
    JOURNAL OF NEUROVIROLOGY, 2019, 25 (04) : 560 - 577
  • [7] Methamphetamine effects on blood-brain barrier structure and function
    Northrop, Nicole A.
    Yamamoto, Bryan K.
    FRONTIERS IN NEUROSCIENCE, 2015, 9
  • [8] Breaking down the barrier: The effects of HIV-1 on the blood-brain barrier
    Strazza, Marianne
    Pirrone, Vanessa
    Wigdahl, Brian
    Nonnemacher, Michael R.
    BRAIN RESEARCH, 2011, 1399 : 96 - 115
  • [9] Tight junction complex deregulation by morphine and HIV-1 Tat exposure in an in vitro blood-brain barrier system
    Maubert, M.
    Kercher, K.
    Strazza, M.
    Pirrone, V
    Lin, W.
    Feng, R.
    Nonnemacher, M.
    JOURNAL OF NEUROIMMUNE PHARMACOLOGY, 2017, 12 : S34 - S34
  • [10] Infection of human pericytes by HIV-1 disrupts the integrity of the blood-brain barrier
    Toborek, Michal
    Nakagawa, Shinsuke
    FASEB JOURNAL, 2012, 26